Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Wake Forest University Health Sciences
Stanford University
University of Nebraska
Eastern Cooperative Oncology Group
Atara Biotherapeutics
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Northwestern University
Roswell Park Cancer Institute
AbbVie
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Mayo Clinic
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
University of Wisconsin, Madison
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
University of Chicago
Swiss Cancer Institute
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center